Fact-checked by Grok 2 weeks ago

Ovulation

Ovulation is the physiologic process in which a mature egg, or ovum, is released from the dominant ovarian follicle into the fallopian tube, marking a critical phase of the menstrual cycle essential for human reproduction.^[1] This event typically occurs once per cycle, approximately 14 days before the onset of menstruation in a standard 28-day cycle, though cycle lengths vary among individuals.^[2] The released ovum remains viable for fertilization by sperm for about 12 to 24 hours, during which conception is possible if intercourse occurs.^[3] The menstrual cycle, which encompasses ovulation, is divided into the follicular phase, ovulation itself, and the luteal phase, all regulated by a complex interplay of hormones from the hypothalamus, pituitary gland, and ovaries.^[4] During the follicular phase, follicle-stimulating hormone (FSH) from the anterior pituitary stimulates the growth of several ovarian follicles, one of which becomes dominant and secretes increasing levels of estrogen.^[2] Rising estrogen initially exerts negative feedback on the pituitary to suppress FSH, promoting atresia of subordinate follicles, but eventually triggers positive feedback that induces a surge in both luteinizing hormone (LH) and FSH around mid-cycle.^[4] The LH surge, peaking for 24 to 48 hours, initiates final oocyte maturation, weakens the follicular wall through enzymatic degradation, and causes follicular rupture approximately 36 to 44 hours later, expelling the ovum into the peritoneal cavity where it is captured by the fimbriae of the fallopian tube.^[2] Following ovulation, the ruptured follicle transforms into the corpus luteum under LH stimulation, which produces progesterone to prepare the uterine endometrium for potential implantation.^[4] If fertilization does not occur, the corpus luteum degenerates, progesterone levels decline, and menstruation ensues, restarting the cycle.^[2] Disruptions in ovulation, such as anovulation, can lead to infertility or conditions like polycystic ovary syndrome, highlighting its central role in reproductive health.^[1] Understanding ovulation is vital for fertility tracking, contraception, and assisted reproductive technologies, with methods like basal body temperature charting or ovulation predictor kits relying on its predictable hormonal signals.^[5]

Introduction

Definition and Overview

Ovulation is the physiologic process by which a mature oocyte, or egg cell, is released from the dominant ovarian follicle into the peritoneal cavity, where it is subsequently captured by the fimbriae of the fallopian tube for potential fertilization.^[1] This event marks a critical phase in the female reproductive cycle, occurring primarily in mammals as part of gamete production and release.^[6] In humans, ovulation involves the ovaries, paired gonadal structures that contain numerous follicles at various developmental stages. Follicles begin as primordial structures, consisting of an oocyte surrounded by a single layer of flattened granulosa cells; they progress to primary follicles with cuboidal granulosa cells, secondary follicles featuring multiple granulosa layers and an emerging theca, and finally the mature Graafian follicle, characterized by a fluid-filled antrum and a prominent oocyte.^[7] The Graafian follicle, typically 15-25 mm in diameter, reaches the ovarian surface, where enzymatic degradation and contraction lead to rupture of the overlying surface epithelium, expelling the oocyte.^[6] Unlike in induced ovulators such as rabbits and cats, human ovulation is spontaneous, occurring cyclically without requiring copulatory stimulation.^[8] Ovulation generally transpires mid-cycle, approximately 36-40 hours after the preovulatory surge in luteinizing hormone, aligning with day 14 in an idealized 28-day menstrual cycle.^[4] However, significant variability exists; normal cycle lengths range from 21 to 35 days, with ovulation occurring about 14 days before the subsequent menses, leading to potential shifts in timing across individuals and cycles.^[9] This process is hormonally triggered and plays a pivotal role in fertility by providing the ovum for possible sperm encounter in the fallopian tube.^[1]

Role in Reproduction

Ovulation plays a central role in mammalian reproduction by releasing a mature ovum from the ovarian follicle into the fallopian tube, where it becomes available for fertilization by sperm.^[10] The ovum remains viable for fertilization for approximately 12-24 hours following its release, creating a narrow temporal window for conception.^[11] During this period, sperm can survive in the female reproductive tract for up to 3-5 days, allowing intercourse occurring days prior to ovulation to result in fertilization and subsequent zygote formation if viable sperm are present.^[12] This synchronization of gamete viability ensures efficient internal fertilization, a key adaptation in mammals that protects the gametes from external environmental hazards and supports embryonic development within the reproductive tract.^[13] From an evolutionary standpoint, ovulation represents an adaptation for internal fertilization in mammals, facilitating the retention and nourishment of the developing embryo in a protected uterine environment. In humans, ovulation is typically mono-ovular, releasing a single ovum per cycle, which contrasts with poly-ovulation in litter-bearing species such as rodents and pigs, where multiple ova are released to support larger litters and enhance reproductive output in response to environmental pressures.^[14] This mono-ovulation in primates, including humans, is linked to genetic factors like variations in the BMP15 gene, which regulate follicle development and promote single-ovum release, potentially optimizing energy allocation for prolonged gestation and offspring care in species with high parental investment.^[15] Beyond reproduction, ovulation contributes to broader physiological effects through fluctuations in estrogen and progesterone levels across the menstrual cycle, influencing non-reproductive systems. Elevated estrogen during the periovulatory phase supports bone health by promoting osteoblast activity and inhibiting bone resorption, thereby maintaining bone density.^[16] Progesterone surges post-ovulation further protect bone metabolism in ovulatory cycles, reducing the risk of bone loss compared to anovulatory states.^[17] These hormonal shifts also affect mood, with progesterone metabolites like allopregnanolone modulating emotion processing and potentially alleviating or exacerbating mood symptoms in susceptible individuals.^[18] Additionally, cycle-related estrogen and progesterone variations influence metabolism, altering energy expenditure and substrate utilization patterns, such as increased fat oxidation during the luteal phase.^[19] The recognition of ovulation in medical literature dates back to 1672, when Regnier de Graaf first described the ovarian follicles and corpus luteum in his treatise De Mulierum Organis Generationi Inserviceintibus, providing early insights into the ovarian structures involved in egg release.^[20]

The Ovulatory Cycle

Follicular Phase

The follicular phase of the menstrual cycle spans from the first day of menstruation to the onset of ovulation, typically lasting 10 to 16 days in cycles of 21 to 35 days, though it is often cited as days 1 to 14 in a standard 28-day cycle.^[4]^[21] This phase begins immediately after the regression of the corpus luteum from the previous cycle, which leads to a decline in progesterone and estrogen levels, thereby removing negative feedback on the hypothalamic-pituitary axis and initiating follicle recruitment.^[4] Folliculogenesis during this phase involves the recruitment and growth of a cohort of primordial follicles, which are activated from the ovarian reserve established in utero, progressing through preantral and antral stages to select a single dominant follicle.^[7] Multiple primordial follicles are initially recruited under the influence of follicle-stimulating hormone (FSH), with granulosa cells proliferating to surround the oocyte and form multilayered structures, while theca cells differentiate externally to support further development.^[4]^[21] The process culminates in the selection of one dominant follicle around days 5 to 7, while subordinate follicles undergo atresia due to reduced FSH sensitivity.^[4] Key cellular events include the oocyte remaining arrested in prophase I of meiosis throughout the phase, enclosed within the cumulus-oocyte complex, preventing further maturation until the luteinizing hormone surge.^[22] Antrum formation occurs as the follicle reaches approximately 400 μm in diameter, where fluid accumulates between granulosa cells, creating a fluid-filled cavity that expands and displaces the granulosa layers, with the oocyte positioned eccentrically.^[23] Selection of the dominant follicle is facilitated by anti-Müllerian hormone (AMH) produced by granulosa cells of smaller antral follicles, which inhibits FSH responsiveness in competitors, allowing the dominant one to continue growing beyond 10 mm.^[24] Vascular and structural changes are prominent in the theca layer, where endothelial cells are recruited from surrounding ovarian stroma to form a dense capillary network, increasing blood supply to deliver nutrients and hormones essential for the dominant follicle's expansion to 20-25 mm.^[25] This vascularization strengthens the theca interna, preparing the follicle wall for the mechanical stresses of impending rupture while maintaining avascularity in the granulosa layer to regulate the microenvironment.^[26]

Ovulation Event

The ovulation event is triggered by a preovulatory surge in luteinizing hormone (LH), which binds to receptors on the granulosa and theca cells of the dominant ovarian follicle, initiating a cascade of intracellular signals that culminate in follicular rupture.^[1] This LH surge, typically peaking 10-12 hours after its onset, promotes the synthesis of proteolytic enzymes, including matrix metalloproteinases (MMPs) such as collagenases, and stimulates prostaglandin production within the follicle to facilitate enzymatic degradation of the extracellular matrix in the follicular wall.^[27]^[28] These enzymes, particularly MMP-2 and MMP-9, target collagen fibers and basement membranes, weakening the apical region of the follicle and enabling its breakdown without causing widespread ovarian damage.^[29] The sequence of mechanical events begins with progressive swelling of the mature Graafian follicle due to increased follicular fluid accumulation and vascular permeability induced by the LH surge, causing the follicle to protrude through the ovarian surface epithelium.^[30] Approximately 1-2 hours before rupture, the overlying ovarian surface cells detach, forming the stigma—a localized, avascular thinning of the tunica albuginea and granulosa cell layers at the follicle apex.^[30] Rupture then occurs rapidly at this site through a combination of enzymatic digestion and localized contractions mediated by prostaglandins and smooth muscle-like cells in the theca externa, expelling the cumulus-oocyte complex (consisting of the oocyte surrounded by cumulus cells and hyaluronic acid matrix) directly into the peritoneal cavity. Immediately following expulsion, the finger-like fimbriae of the infundibulum on the fallopian tube actively sweep and capture the complex via ciliary action and muscular contractions, drawing it into the oviduct.^[1] The rupture phase itself typically lasts 15-45 minutes in humans, though the full process from LH surge onset to complete expulsion spans about 24-36 hours.^[30] Oocyte transport from the ovarian surface to the ampulla of the fallopian tube, where fertilization is most likely, requires several hours, driven by tubal peristalsis and cilia.^[31] At the microscopic level, the LH surge concurrently triggers resumption of meiosis in the oocyte, which has been arrested in prophase I (dictyate stage) since fetal development; this leads to germinal vesicle breakdown within 12-24 hours of the surge, followed by progression through meiosis I and extrusion of the first polar body near the time of follicular rupture.^[32]^[33] The oocyte then arrests at metaphase II until fertilization, ensuring chromosomal segregation only upon sperm entry.^[34] This event marks the transition from the follicular phase, where the oocyte matured within the growing follicle.^[4]

Luteal Phase

The luteal phase begins immediately after ovulation, when the ruptured ovarian follicle undergoes a transformative process known as luteinization to form the corpus luteum. This structure develops from the granulosa and theca interna cells of the dominant follicle, which hypertrophy, accumulate lipid droplets, and differentiate into steroidogenic luteal cells. The resulting corpus luteum is a highly vascularized, temporary endocrine gland approximately 1-2 cm in diameter, characterized by its yellowish coloration due to carotenoid pigments.^[35] The primary function of the corpus luteum is to secrete progesterone, with lesser amounts of estrogen, to support the uterine endometrium for potential embryo implantation. Progesterone induces secretory changes in the endometrial glands and stromal cells, promoting vascularization and nutrient accumulation essential for early pregnancy maintenance. In the absence of fertilization and human chorionic gonadotropin (hCG) from an implanted embryo, the corpus luteum maintains functionality for about 12-14 days before regressing.^[36]^[35] If pregnancy does not occur, the corpus luteum undergoes luteolysis, a programmed regression process primarily mediated by prostaglandin F2α (PGF2α) released from the uterine endometrium. This prostaglandin triggers apoptosis and structural breakdown of luteal cells, reducing progesterone production and leading to endometrial desquamation and menstruation. The decline in progesterone levels signals the onset of the next menstrual cycle.^[37]^[35] In humans, the luteal phase exhibits relatively fixed duration of approximately 14 days, contributing to the consistency observed in the latter half of the menstrual cycle. This stability contrasts with the more variable length of the preceding follicular phase, where differences of several days can occur due to fluctuating follicular development times; overall cycle variability thus primarily stems from follicular phase differences.^[4]^[38]

Regulation

Hormonal Mechanisms

Ovulation is regulated by the hypothalamic-pituitary-ovarian (HPO) axis, a key endocrine pathway that coordinates reproductive function through interconnected hormonal signals. The hypothalamus releases gonadotropin-releasing hormone (GnRH) in pulsatile bursts from neurons in the preoptic area and arcuate nucleus, which travel via the hypophyseal portal system to stimulate gonadotroph cells in the anterior pituitary. These pulses prompt the synthesis and secretion of follicle-stimulating hormone (FSH) and luteinizing hormone (LH), which in turn act on the ovaries to drive follicular development and steroidogenesis.^[39]^[40]^[41] During the follicular phase, rising FSH levels, driven by frequent GnRH pulses (every 60-120 minutes), promote the recruitment and growth of ovarian follicles by stimulating granulosa cell proliferation and expression of aromatase, leading to increased estrogen production. Initially, low estrogen levels exert negative feedback on the hypothalamus and pituitary, suppressing GnRH and gonadotropin release to selectively favor the dominant follicle. As the dominant follicle matures and estrogen (estradiol) concentrations rise above a threshold (approximately 200 pg/mL), this feedback switches to positive, amplifying GnRH pulsatility and enhancing pituitary sensitivity to GnRH.^[4]^[21]^[42] The positive estrogen feedback culminates in the preovulatory LH surge, triggered by sustained estradiol levels exceeding approximately 200 pg/mL for about 50 hours, resulting in a 10-fold increase in circulating LH from baseline (typically >40 IU/L at peak). This surge, lasting 24-48 hours, is characterized by rapid LH secretion peaking 10-12 hours before ovulation, which induces final oocyte maturation, cumulus expansion, and follicular rupture. FSH also rises modestly (2-3 fold) during this event, supporting these processes.^[4]^[43]^[44] In the luteal phase following ovulation, the corpus luteum forms and secretes high levels of progesterone (peaking at 10-20 ng/mL), which inhibits GnRH pulse frequency (slowing to every 3-4 hours) and suppresses pituitary gonadotropin release, preventing premature follicular recruitment. This negative feedback maintains elevated progesterone until luteolysis, approximately 10-14 days post-ovulation in non-pregnant cycles, when prostaglandin F2α from the endometrium triggers corpus luteum regression, dropping progesterone and allowing cycle resumption.^[45]^[4]^[46]

Neural and Environmental Influences

The autonomic nervous system plays a crucial role in modulating ovarian function during ovulation, primarily through sympathetic innervation that influences blood flow and follicular dynamics. Sympathetic nerves, arriving via the superior ovarian nerve and ovarian plexus, exert vasoconstrictor effects on ovarian vasculature, thereby regulating blood supply to developing follicles and the corpus luteum.^[47] In contrast, parasympathetic inputs via the vagus nerve provide modulatory effects, though sympathetic activity predominates in acute responses like those during the ovulatory surge.^[48] Circadian rhythms, orchestrated by the suprachiasmatic nucleus (SCN) in the hypothalamus, synchronize the timing of ovulation with environmental light-dark cycles. The SCN generates daily oscillatory signals that modulate gonadotropin-releasing hormone (GnRH) pulse frequency, with higher amplitude pulses occurring in the late afternoon to trigger the luteinizing hormone (LH) surge necessary for ovulation.^[49] Disruptions in light exposure, such as constant light regimes, can desynchronize these rhythms, delaying or inhibiting the preovulatory LH peak and thus altering ovulation timing.^[50] This neural clock mechanism ensures ovulation aligns with optimal reproductive windows, integrating photoperiod cues from the retinohypothalamic tract.^[51] Environmental factors exert significant non-hormonal influences on ovulation through interactions with neural pathways. Chronic stress elevates cortisol levels, which suppress GnRH pulsatility in the hypothalamus, reducing LH secretion and potentially delaying or preventing ovulation.^[52] This effect is mediated via glucocorticoid receptors in the hypothalamic-pituitary-gonadal axis, where sustained cortisol exposure mimics a low-energy state, prioritizing survival over reproduction.^[53] Nutritional status, signaled by adipocyte-derived leptin, links energy balance to ovulatory competence; adequate leptin levels stimulate hypothalamic kisspeptin neurons to maintain GnRH pulses, whereas energy deficits lower leptin, inhibiting ovulation as seen in undernutrition or exercise-induced amenorrhea.^[54] Age-related decline, particularly during perimenopause, involves cumulative neural changes such as reduced hypothalamic sensitivity to feedback signals, compounded by environmental stressors like oxidative damage, leading to irregular GnRH secretion and fewer ovulatory cycles.^[55] In comparative physiology, ovulation mechanisms differ markedly between species, highlighting neural reflex pathways. Rabbits exhibit induced ovulation triggered by coitus, where sensory stimulation from mating activates a neural reflex arc involving vagal afferents and hypothalamic GnRH release, often mediated by nerve growth factor (NGF) in semen.^[56] This contrasts with the spontaneous ovulation in humans, driven by endogenous circadian and hormonal oscillators without requiring external copulatory cues, though both share core GnRH-LH pathways.^[57] Such differences underscore the evolutionary adaptability of neural-environmental integration in reproductive timing.^[58]

Detection and Timing

Physiological Signs

One of the most recognizable physiological signs of ovulation is mittelschmerz, a mid-cycle pelvic pain experienced by over 40% of women, resulting from the rupture of the ovarian follicle during egg release.^[59] This pain, often unilateral and localized to the lower abdomen or pelvis, typically lasts from a few minutes to several hours and may be sharp or cramp-like.^[59] Changes in cervical mucus provide another key indicator, as rising estrogen levels in the days leading up to ovulation cause the mucus to become clear, slippery, and stretchy, resembling raw egg whites in consistency.^[4] This transformation, peaking around the estrogen surge, creates an optimal environment for sperm survival and transport through the cervix by reducing viscosity and enhancing lubrication.^[60] Basal body temperature (BBT) exhibits a subtle but detectable shift post-ovulation, rising by 0.5 to 1°F due to the thermogenic effects of progesterone produced by the corpus luteum.^[5] This elevation, which occurs within 24 to 48 hours after ovulation and remains sustained until the onset of menstruation (or longer if pregnancy occurs), serves as a retrospective marker of the ovulatory event when tracked daily upon waking.^[5] Additional physiological signs linked to hormonal fluctuations during ovulation include increased libido, driven by elevated estrogen and testosterone levels that enhance sexual motivation in the periovulatory window.^[61] Some women also report breast tenderness or heightened sensory perceptions, such as improved smell or taste sensitivity, attributable to the mid-cycle estrogen peak.^[62]

Predictive Methods

Calendar methods for predicting ovulation rely on tracking the lengths of multiple menstrual cycles to estimate the fertile window. Users record the number of days from the first day of one period to the next over 6 to 12 cycles, identifying the shortest and longest cycle lengths. The first day of the fertile period is calculated by subtracting 18 days from the shortest cycle length, while the last fertile day is determined by subtracting 11 days from the longest cycle length; ovulation is generally estimated to occur around 14 days before the anticipated start of the next period. For women with consistent cycles between 26 and 32 days, a simplified standard days method identifies days 8 through 19 as fertile. These approaches are simple and cost-free but have limited accuracy, with typical-use failure rates leading to unintended pregnancies in up to 24% of users per year.^[63] Ovulation predictor kits (OPKs) offer a more direct biochemical approach by detecting the mid-cycle luteinizing hormone (LH) surge in urine, which signals ovulation within 24 to 36 hours. These over-the-counter tests typically involve daily urine sampling starting around cycle day 10, with a positive result indicated by a color change or line intensity when LH levels exceed a threshold of about 20 to 25 mIU/ml. OPKs demonstrate high sensitivity, often exceeding 90% for detecting the LH surge compared to ultrasound confirmation, and can identify the fertile window encompassing the five days before and the day of ovulation. However, they may produce false positives in up to 10% of cases, particularly in women with polycystic ovary syndrome (PCOS) due to chronically elevated baseline LH levels that mimic a surge.^[64]^[65]^[66]^[67] Transvaginal ultrasound provides a precise imaging-based method for monitoring ovulation, primarily used in clinical settings for fertility assessment. This technique visualizes ovarian follicles from the early follicular phase, tracking their growth until a dominant follicle reaches 18 to 20 mm in diameter, at which point ovulation is imminent. Ovulation is confirmed by observing follicle rupture, characterized by the follicle's disappearance and the presence of echogenic free fluid in the pelvis. As the reference standard for ovulation detection, transvaginal ultrasound achieves near-100% accuracy when combined with hormonal assays but requires specialized equipment and expertise.^[68]^[64] Wearable technologies enable continuous, non-invasive ovulation prediction through physiological sensors integrated into devices like wristbands or patches. These tools monitor parameters such as basal body temperature (BBT), which rises 0.3 to 0.5°C post-ovulation due to progesterone; heart rate variability, which increases in the periovulatory phase; and cervical fluid changes via electrical impedance, reflecting electrolyte shifts from rising estrogen levels. Algorithms processing these data, often via smartphone apps, predict the fertile window with accuracies around 87%, sensitivities of 69%, and specificities of 92% in validation studies. Examples include the Ava bracelet, which combines multiple metrics for real-time fertility tracking, and the Oura Ring, validated for ovulation detection in a 2025 study.^[69]^[70]^[71] These offer greater convenience for daily use compared to intermittent testing.

Disorders

Anovulation and Hypo-ovulation

Anovulation refers to the absence of ovulation, where the ovaries fail to release an oocyte during a menstrual cycle, often resulting in irregular or absent menstruation.^[72] Hypo-ovulation, also known as oligo-ovulation, describes infrequent ovulation, typically fewer than eight ovulatory cycles per year, leading to prolonged or irregular menstrual intervals.^[73] These conditions disrupt the normal ovulatory cycle and are primary contributors to female infertility, as no egg is available for fertilization.^[74] Chronic anovulation and hypo-ovulation affect approximately 6-15% of women of reproductive age, with higher rates observed in those seeking fertility evaluation.^[75] Among women experiencing infertility, ovulatory disorders like these account for 25-30% of cases, and nearly all affected individuals face challenges conceiving naturally without intervention.^[76] The most common cause of anovulation is polycystic ovary syndrome (PCOS), responsible for 70-80% of anovulatory infertility cases, characterized by hyperandrogenism, insulin resistance, and disrupted follicular development.^[77] Hypothalamic amenorrhea, often triggered by excessive stress, significant weight loss, or intense exercise, suppresses gonadotropin-releasing hormone (GnRH) secretion, leading to insufficient follicle-stimulating hormone (FSH) and luteinizing hormone (LH) for ovulation.^[78] Premature ovarian insufficiency (POI), affecting about 1% of women under 40, results from accelerated follicular depletion due to genetic, autoimmune, or idiopathic factors, causing elevated FSH and diminished ovarian reserve.^[75] Diagnosis typically begins with a history of irregular menses and may include monitoring for an absent LH surge via urine or serum tests, which normally precedes ovulation by 24-36 hours.^[79] Basal body temperature (BBT) charting often reveals no mid-cycle thermal shift, as progesterone—the hormone responsible for the post-ovulatory rise—remains low.^[64] Transvaginal ultrasound can confirm the absence of a corpus luteum or follicular rupture, while mid-luteal phase progesterone levels below 3 ng/mL indicate anovulation;^[80] FSH assays help differentiate causes, such as low levels in hypothalamic amenorrhea versus elevated levels in POI.

Other Ovulatory Abnormalities

Luteal phase defect (LPD), also known as luteal phase deficiency, is characterized by a shortened luteal phase lasting 10 days or less, resulting from inadequate progesterone production by the corpus luteum after ovulation.^[80] This condition impairs the development of a secretory endometrium necessary for embryo implantation, often leading to infertility or early pregnancy loss such as miscarriage.^[45] Diagnosis typically involves measuring serial serum progesterone levels during the mid-luteal phase, with values below 10 ng/mL indicating insufficiency; endometrial biopsy may also reveal inadequate glandular development, though it is less commonly used due to its invasiveness.^[81] Potential causes include disruptions in follicular development, such as subtle ovulatory dysfunction, or endometrial resistance to progesterone, though the exact etiology remains debated in clinical practice.^[82] Premature ovulation refers to the early release of an oocyte before the dominant follicle reaches optimal maturity, often triggered by an untimely luteinizing hormone (LH) surge in response to elevated follicle-stimulating hormone (FSH) levels.^[83] In women approaching advanced reproductive age, rising FSH concentrations accelerate follicular progression, shortening the follicular phase and increasing the likelihood of this abnormality, which can reduce oocyte quality and fertilization success.^[84] Certain medications, such as higher doses of clomiphene citrate used for ovulation induction, may also provoke premature ovulation by overstimulation without adequate suppression of endogenous LH, complicating timed insemination or embryo transfer.^[85] Multifollicular ovulation occurs when multiple ovarian follicles mature and release eggs in a single cycle, deviating from the typical monofollicular pattern and elevating the risk of dizygotic twinning.^[86] This phenomenon arises naturally in an estimated 5-10% of cycles, often linked to enhanced follicular recruitment, but it is more frequently induced by treatments like clomiphene citrate, which promotes the development of several follicles greater than 10 mm in diameter.^[87] The resulting multiple gestation rate can reach 5-12% with such interventions, compared to less than 1% in unstimulated cycles, underscoring the need for careful monitoring to balance fertility outcomes against obstetric risks.^[88] These ovulatory abnormalities carry specific reproductive risks beyond infertility. For instance, multifollicular ovulation or associated tubal transport irregularities can predispose to ectopic pregnancy, where implantation occurs outside the uterus, with rates approaching 1-2% in affected cycles similar to those in general infertility populations.^[89] In cases of untreated hyperresponse leading to excessive follicular growth, ovarian hyperstimulation syndrome (OHSS) may develop, characterized by ovarian enlargement, fluid shifts, and potential vascular complications, though it is rarer without exogenous gonadotropins.^[90] Early recognition through ultrasound and hormone assays is essential to mitigate these complications.

Clinical Interventions

Ovulation Induction

Ovulation induction is a therapeutic approach employed to stimulate the development and release of oocytes in women experiencing anovulatory infertility, particularly those with polycystic ovary syndrome (PCOS) or classified under World Health Organization (WHO) Group II anovulation.^[91] This intervention addresses the absence of ovulation, a common cause of infertility, by mimicking or enhancing the natural hormonal processes that regulate the menstrual cycle.^[92] The primary pharmacological agents for ovulation induction include clomiphene citrate, letrozole, and gonadotropins. Clomiphene citrate, a selective estrogen receptor modulator, acts as an anti-estrogen by blocking negative feedback at the hypothalamus and pituitary gland, thereby increasing the pulsatile release of gonadotropin-releasing hormone (GnRH) and subsequent secretion of follicle-stimulating hormone (FSH).^[93] This mechanism promotes follicular development and ovulation in 70-85% of treated women with anovulation.^[94] Letrozole, an aromatase inhibitor, reduces estrogen production by inhibiting the conversion of androgens to estrogens, which indirectly boosts FSH levels and is particularly effective in PCOS patients, yielding higher ovulation and live birth rates compared to clomiphene citrate.^[95] Letrozole demonstrates superior efficacy in PCOS, with a cumulative live birth rate of 27.5% over up to five cycles compared to 19.1% for clomiphene.^[96] Gonadotropins, administered as injectable recombinant or urinary-derived FSH (with or without luteinizing hormone [LH] activity), directly stimulate ovarian follicle growth and are reserved for cases resistant to oral agents, achieving ovulation in up to 90% of cycles when properly dosed.^[97] In medication-resistant cases, particularly in PCOS, surgical interventions such as laparoscopic ovarian drilling (LOD) may be employed. LOD involves creating small perforations in the ovarian stroma using electrocautery, laser, or ultrasound to reduce androgen levels and restore ovulatory cycles. It achieves ovulation rates comparable to medical treatments (odds ratio 0.96, 95% CI 0.73–1.28), with similar clinical pregnancy rates (OR 0.86, 95% CI 0.72–1.03) but lower risks of multiple pregnancies (Peto OR 0.34, 95% CI 0.18–0.66) and ovarian hyperstimulation syndrome (Peto OR 0.25, 95% CI 0.07–0.91).^[98] Treatment protocols emphasize individualized dosing and close monitoring to optimize outcomes while minimizing complications. For clomiphene citrate and letrozole, oral administration typically begins on cycle days 3-5 at starting doses of 50 mg and 2.5-5 mg daily, respectively, for 5 days, with escalation in subsequent cycles if ovulation does not occur.^[99] Gonadotropin protocols often employ a low-dose step-up regimen, initiating with 75 IU of FSH daily and incrementally increasing by 37.5-75 IU every 4-7 days based on ovarian response, to avoid overstimulation.^[100] Monitoring involves serial transvaginal ultrasound to assess follicle size (targeting 18-20 mm for trigger) and serum estradiol measurements to track estrogen production, guiding hCG administration for final oocyte maturation and preventing excessive follicular recruitment.^[101] Success rates for ovulation induction vary by agent and patient factors, with clinical pregnancy rates of 15-25% per cycle and cumulative rates reaching 40-70% over multiple cycles.^[97] Key risks include ovarian hyperstimulation syndrome (OHSS), a potentially serious condition involving fluid shifts and ovarian enlargement, occurring in 1-5% of cycles with severe cases in less than 1%; and multiple gestations, affecting 10-30% of resulting pregnancies due to multifollicular development.^[102] These risks are mitigated through careful monitoring and cycle cancellation if more than 3-4 mature follicles develop.^[103]

Ovulation Suppression

Ovulation suppression is primarily employed in hormonal contraceptives to inhibit the luteinizing hormone (LH) surge and prevent follicular development, thereby avoiding pregnancy.^[104] This approach is also used medically to manage conditions like endometriosis by reducing ovarian activity.^[105] Combined oral contraceptives, containing estrogen and progestin, suppress ovulation by inhibiting gonadotropin-releasing hormone (GnRH) from the hypothalamus, which in turn decreases follicle-stimulating hormone (FSH) and LH secretion from the pituitary, preventing follicular maturation.^[104] Progestin-only pills and implants achieve suppression through continuous progestin feedback that inhibits the mid-cycle LH surge, altering cervical mucus to impede sperm transport and thinning the endometrium to reduce implantation potential; ovulation inhibition occurs in approximately 99% of cycles with consistent use.^[106]^[107] GnRH agonists, such as leuprolide, are utilized for conditions like endometriosis; they initially stimulate but then downregulate pituitary GnRH receptors, leading to suppressed gonadotropin release, anovulation, and hypoestrogenism.^[105] Emergency contraception with ulipristal acetate works by selectively binding progesterone receptors to block the LH surge, delaying ovulation even if administered shortly before the LH peak, with effectiveness up to 5 days post-unprotected intercourse.^[108] Common side effects include amenorrhea due to endometrial suppression, particularly with progestin-only methods and GnRH agonists.^[109] Long-term use of certain progestin-only injectables, like depot medroxyprogesterone acetate, may lead to reversible bone density loss, primarily in the first two years, due to hypoestrogenism.^[109] Fertility typically returns within 1-3 months after discontinuation of combined oral contraceptives or implants, though it may take up to 7-9 months for injectables.^[104]^[109]

References

[1]
Physiology, Ovulation - StatPearls - NCBI Bookshelf - NIH
Ovulation is a physiologic process defined by the rupture of the dominant follicle of the ovary. This releases an egg into the abdominal cavity.
[2]
Physiology, Menstrual Cycle - StatPearls - NCBI Bookshelf
Sep 27, 2024 · Ovulation typically occurs approximately 36 to 44 hours after the onset of the LH surge. The cervical changes that began during the follicular ...
[3]
Ovulation signs: When is conception most likely? - Mayo Clinic
Ovulation is the process in which an egg is released from an ovary. The egg can be fertilized for about 12 to 24 hours after it's released.
[4]
The Normal Menstrual Cycle and the Control of Ovulation - NCBI - NIH
Aug 5, 2018 · In humans, ovulation probably occurs randomly from either ovary during any given cycle. Of interest, some studies have suggested that ovulation ...
[5]
Physiology, Ovulation And Basal Body Temperature - NCBI - NIH
Women have used charting average basal body temperatures over the length of a menstrual period has been a tool to determine if ovulation has occurred or not.
[6]
Morphology and Physiology of the Ovary - Endotext - NCBI Bookshelf
Jan 30, 2012 · The preantral or Class 1 phase is divided into three major stages: the primordial, primary, and secondary follicle stages. Altogether, the ...
[7]
Embryology, Ovarian Follicle Development - StatPearls - NCBI - NIH
Aug 3, 2025 · Ovarian follicle development occurs in 2 distinct phases—the gonadotropin-independent growth (pre-antral phase) and the gonadotropin-dependent ...
[8]
QnAs with Günter P. Wagner - PMC
Sep 30, 2019 · In humans, ovulation happens spontaneously every 4 weeks, but there are many animals, such as rabbits and cats, that don't ovulate unless there ...
[9]
Your menstrual cycle | Office on Women's Health
Jan 13, 2025 · Each woman's cycle length may be different, and the time between ovulation and when the next period starts can be anywhere from one week (7 days) ...
[10]
Animal Reproductive Structures and Functions | Organismal Biology
Mature eggs are released from the ovary into the oviducts (aka fallopian tubes) where they are either fertilized (in animals that reproduce via internal ...
[11]
Current ovulation and luteal phase tracking methods and ... - NIH
Therefore ovulation occurs on average 14–19 days after the start of the menstrual cycle, and following ovulation the egg survives for 12–24 hours (Figure 1).
[12]
Sperm: How long do they live after ejaculation? - Mayo Clinic
Sperm typically can stay alive for about 3 to 5 days within the cervix, uterus and fallopian tubes. It's possible for an egg to be fertilized at any point ...
[13]
Fertilization - Molecular Biology of the Cell - NCBI Bookshelf - NIH
Fertilization is the fusion of egg and sperm, saving them and forming a new organism. It begins with sperm binding to the egg, inducing the acrosome reaction.Missing: evolution | Show results with:evolution
[14]
Evolutionary Origin of Bone Morphogenetic Protein 15 and Growth ...
We also observed that mono-ovulating species had lower global substitution rates than the polyovulating animals in all the proteins we tested. This was ...
[15]
Mono or poly ovulation, evolutionary role of the BMP15 gene ... - ANR
The concept is that fully functional BMP15 would strictly control mono-ovulation, while altered BMP15 action would allow poly-ovulation to occur. Using mono- ( ...
[16]
Non-reproductive Effects of Anovulation: Bone Metabolism in ... - NIH
This study systematically examined the influence of ovulation and anovulation on the bone metabolism of premenopausal women.
[17]
Progesterone and Bone: Actions Promoting Bone Health in Women
... estrogen levels [11]. The purpose of this paper and meta-analyses is to study recent clinical evidence that endogenous progesterone plays a role in bone health.
[18]
Progesterone – Friend or foe? - ScienceDirect.com
Progesterone, or allopregnanolone, influence emotion processing and are likely causal factors for the mood symptoms experienced by women with premenstrual ...
[19]
Menstrual cycle rhythmicity: metabolic patterns in healthy women
Oct 1, 2018 · The menstrual cycle is an essential life rhythm governed by interacting levels of progesterone, estradiol, follicular stimulating, and luteinizing hormones.
[20]
Lessons from bioengineering the ovarian follicle - PubMed Central
Sitting proudly on my desk is a first edition of Regnier De Graaf's treatise on the ovarian follicle (de Graaf 1672), given to me by my great friend Najiba ...
[21]
Proliferative and Follicular Phases of the Menstrual Cycle - NCBI - NIH
Sep 12, 2022 · The follicular phase of the female menstrual cycle involves the maturation of ovarian follicles, preparing them for release during ovulation.
[22]
Prophase I arrest and progression to metaphase I in mouse oocytes
Mammalian oocytes are arrested at prophase I until puberty when luteinizing hormone (LH) induces resumption of meiosis of follicle-enclosed oocytes.
[23]
https://academic.oup.com/biolreprod/article/82/6/1021/2557926
[24]
Anti-Müllerian hormone promotes pre-antral follicle growth, but ...
May 9, 2016 · Anti-Müllerian hormone promotes pre-antral follicle growth, but inhibits antral follicle maturation and dominant follicle selection in primates ...
[25]
Regulation of the ovarian follicular vasculature
Apr 12, 2006 · As the follicle continues to develop, endothelial cells are recruited to the thecal layer from the blood vessels in the adjacent ovarian stroma.
[26]
Theca: the forgotten cell of the ovarian follicle in - Reproduction journal
Once follicle growth is activated and a thecal layer has been recruited, a follicle develops its own vascular network within the surrounding thecal layer (see ...
[27]
Inflammation and Human Ovarian Follicular Dynamics - PMC
The luteinizing hormone (LH) surge induces cyclic adenosine ... enzymes to degrade the follicle's connective tissue and cause ovulation. In ...
[28]
Prostaglandin E2 Acts via Multiple Receptors to Regulate ...
Sep 25, 2008 · These data suggest a key role for PGE2 in ovulation as a mediator of proteolytic degradation of the follicle wall. PGE2 alone or in combination ...Missing: enzymatic | Show results with:enzymatic
[29]
Luteinizing hormone induces ovulation via tumor necrosis factor α ...
Sep 16, 2015 · More recently, elegant studies in medaka have shown that follicle rupture involves the initial degradation of laminin, a component of the ...
[30]
Ovulation: Parallels With Inflammatory Processes - PMC
... breakdown of the follicular wall at the time of ovulation. Adamts1 knockout ... LH surge and follicle rupture when the ovary undergoes an inflammatory response.
[31]
Studies on the duration of egg transport by the human oviduct. II ...
In all 19 eggs were found in tubes between 24 and 96 hours and 5 eggs were recovered from the endometrial cavity between 96 and 144 hours after LH peak. Since ...Missing: rupture | Show results with:rupture
[32]
Oogenesis - Developmental Biology - NCBI Bookshelf - NIH
With the onset of adolescence, groups of oocytes periodically resume meiosis. Thus, in the human female, the first part of meiosis begins in the embryo, and ...
[33]
Mechanisms of Oocyte Maturation and Related Epigenetic Regulation
In female mammals, meiosis of oocytes starts before birth and sustains at the dictyate stage of meiotic prophase I before gonadotropins-induced ovulation ...
[34]
Morphology and Biochemistry of Ovulation - PMC - PubMed Central
The ovulation process occurs in a coordinated and interrelated way in five complex steps: interruption of granulosa cell proliferation, resumption of meiosis, ...
[35]
Anatomy, Abdomen and Pelvis, Ovary Corpus Luteum - NCBI - NIH
Jan 1, 2023 · Oogenesis occurs in the female embryo before birth but does not complete until puberty. Therefore, an embryo does not form a corpus luteum. ...Bookshelf · Structure And Function · Clinical Significance<|control11|><|separator|>
[36]
Luteal Phase in Assisted Reproductive Technology - PMC - NIH
Dec 7, 2020 · Luteal phase (LP) is the period of time between the transformation of the dominant ovarian follicle into the corpus luteum (CL), shortly after ...
[37]
Possible Mechanisms for Maintenance and Regression of Corpus ...
Pulsatile release of prostaglandin F2α from the uterus leads to the regression of luteal cells and restarts the estrous cycle in most non-primate species.
[38]
A prospective evaluation of luteal phase length and natural fertility
Mar 1, 2018 · A short luteal phase (length of 11 days or less including the day of ovulation) occurred in 18% of observed cycles. Mean luteal phase length was ...
[39]
Hypothalamic-Pituitary-Ovarian Axis - College of Medicine
Regulation of the hypothalamic-pituitary unit is a complex process involving both negative and positive feedback mechanisms in the female.
[40]
Physiology, Follicle Stimulating Hormone - StatPearls - NCBI - NIH
May 1, 2023 · Follicle-stimulating hormone (FSH) is a hormone produced by the anterior pituitary in response to gonadotropin-releasing hormone (GnRH) from the hypothalamus.
[41]
GnRH Pulsatility, the Pituitary Response and Reproductive ...
GnRH pulses stimulate the synthesis and secretion of LH and FSH from the anterior pituitary. Although produced in same gonadotrope cell, concentrations of LH ...
[42]
The Ovarian Cycle - EdTech Books
The culminating event in the cycles is release of the ovum (ovulation), which typically occurs on day 14 in a typical 28-day cycle. Note that not all cycles are ...
[43]
Luteinizing Hormone Action in Human Oocyte Maturation and Quality
The LH surge is characterized by a 10-fold increase in LH levels in the peripheral circulation [113]. The mean duration of the LH surge is 4 days. How serum LH ...
[44]
Characteristics of the urinary luteinizing hormone surge in ... - PubMed
Apr 16, 2007 · Mean LH surge: start = day 14.5 (+/-3.6 SD) (range: 9-26); peak = 41.2 mIU/mg creatinine (+/-20 SD) (range: 12.1-104.0); fold increase = 7.7 ...
[45]
Progesterone and the Luteal Phase: A Requisite to Reproduction - NIH
Within hours of discontinuing GnRH pulses, LH and progesterone levels were undetectable. In women, lacking GnRH due to hypophysectomy, progesterone from ...
[46]
[PDF] compound 6, a synthetic kisspeptin analog, increases plasma ...
Sep 4, 2025 · During the luteal phase, high circulating P4 suppresses GnRH pulse frequency, leading to basal FSH release sufficient to recruit a new wave of ...
[47]
Autonomic nervous regulation of ovarian function by noxious ...
These sympathetic efferents have vasoconstrictor activity in regulating ovarian blood flow and inhibitory activity in ovarian estradiol secretion [19–27].
[48]
Effect of Superior Ovarian Nerve and Plexus Nerve Sympathetic ...
Apr 9, 2019 · These data suggest that the SON plays a predominant role in follicular development, ovulation and pregnancy during ovarian diseases.
[49]
Roles of the cholinergic system and vagal innervation in the ...
The ovaries receive motor innervations from the sympathetic and parasympathetic systems via the vagus nerve and possess afferent fibers travelling sympathetic ...
[50]
Modeling circadian regulation of ovulation timing - Nature
Oct 7, 2020 · The suprachiasmatic nucleus (SCN), where the central clock is located, generates daily signals to trigger surge release of luteinizing hormone ( ...
[51]
Circadian Rhythms in the Neuronal Network Timing the Luteinizing ...
In this review, we will summarize our current understanding of the neuronal networks that underlie circadian rhythms and the luteinizing hormone surge.
[52]
Circadian Clocks in the Ovary - PMC - PubMed Central
On the afternoon of proestrus, the circadian clock in the SCN drives rhythmic release of GnRH that stimulates rhythmic secretion of LH. Circulating LH then ...Missing: frequency | Show results with:frequency
[53]
Cortisol Reduces Gonadotropin-Releasing Hormone Pulse ...
Sep 18, 2008 · A sustained stress-like level of cortisol reduces GnRH pulse frequency in the follicular phase and appears to require the presence of ovarian steroids.
[54]
Neural and endocrine mechanisms underlying stress-induced ...
Dec 1, 2019 · Stress is well-known to inhibit a variety of reproductive processes, including the suppression of episodic Gonadotropin releasing hormone ...
[55]
Leptin signaling and circuits in puberty and fertility - PMC
Leptin action as a signal of energy sufficiency Increases in appetite and motivation for food search, decreases in thermogenesis and locomotor activity, ...
[56]
conserved mechanisms and environmental factors - PMC
The timing of the age-related decline in reproduction function depends on a complex interplay of interacting changes at all levels of the hypothalamic- ...
[57]
New insights of the role of β-NGF in the ovulation mechanism of ...
The main goal of this review is to offer new information regarding the mechanism that regulates coitus-induced ovulation.
[58]
QnAs with Günter P. Wagner - PNAS
Sep 30, 2019 · In humans, ovulation happens spontaneously every 4 weeks, but there are many animals, such as rabbits and cats, that don't ovulate unless there ...
[59]
New insights on a NGF-mediated pathway to induce ovulation in ...
Feb 9, 2018 · To investigate the ovulatory mechanisms triggered by raw semen (RS) in rabbits, we examined the expression of nerve growth factor (NGF)—a ...
[60]
Mittelschmerz Information | Mount Sinai - New York
One in five women have pain around the time of ovulation. This is called mittelschmerz. The pain may occur just before, during, or after ovulation.Missing: prevalence | Show results with:prevalence
[61]
Mittelschmerz - StatPearls - NCBI Bookshelf
May 1, 2023 · Mittelschmerz—or ovulation pain, as it is commonly known today—is a benign preovulatory lower abdominal pain that occurs midcycle (between days ...
[62]
Cervical Mucus: Chart, Stages, Tracking & Fertility - Cleveland Clinic
Dec 18, 2024 · Estrogen increases before ovulation and makes your cervix produce the fertile, egg-white mucus. It's your body's way of making it easy for ...Missing: source | Show results with:source
[63]
Female social and sexual interest across the menstrual cycle
May 27, 2010 · Around the time of ovulation, normally cycling women commonly experience increased libido, sexual interest and attraction towards potential ...Missing: signs | Show results with:signs
[64]
Ovulation Symptoms: 12 Signs of Ovulation - TheBump.com
Oct 7, 2025 · Tender breasts or sore nipples can be another sign of ovulation, thanks to the rush of hormones entering your body right before and after ...
[65]
Rhythm method for natural family planning - Mayo Clinic
Mar 7, 2023 · To use the rhythm method, you track your menstrual history to predict when you'll ovulate. This helps you determine when you're most likely to ...Overview · Risks · How You Prepare
[66]
Detection of ovulation, a review of currently available methods - PMC
The fertility window begins approximately 3–5 days (sperm lifespan) before ovulation and continues to a point approximately 1–2 days (oocyte lifespan) after ...Missing: calendar | Show results with:calendar<|separator|>
[67]
Similar accuracy and patient experience with different one ... - PubMed
Sep 24, 2024 · Ovulation predictor kit surge detection accuracy compared with blood LH surge was similar across the five kits (Easy@Home, 95.88%; Wondfo, 94.85 ...
[68]
Ovulation home test: MedlinePlus Medical Encyclopedia
Apr 1, 2023 · Rarely, false positive results can occur. This means the test kit may falsely predict ovulation. Considerations. Expand Section. Talk to your ...Missing: PCOS | Show results with:PCOS
[69]
Treatment of infertility in women with polycystic ovary syndrome
Infertile women with PCOS may present with better general oocyte and embryo quality rates; however, the clinical pregnancy and live birth rates are similar to ...Missing: OPK | Show results with:OPK
[70]
Role of Transvaginal Sonography in the Diagnosis of Female Infertility
Dec 6, 2023 · By closely monitoring follicular development, clinicians can predict and precisely time the occurrence of ovulation.
[71]
Tracking of menstrual cycles and prediction of the fertile window via ...
Aug 13, 2022 · Based on BBT and HR, we developed algorithms that predicted the fertile window with an accuracy of 87.46%, sensitivity of 69.30%, specificity of ...
[72]
The effectiveness of cervical mucus electrical impedance compared ...
May 6, 2024 · We report that pre-ovulatory electrical impedance patterns demonstrated higher sensitivity, specificity, and accuracy for determining the fertility window when ...
[73]
Anovulatory Cycle: What Is It, Causes, Treatment, and More | Osmosis
Sep 29, 2025 · An anovulatory cycle is a menstrual cycle in which ovulation, or the release of an egg from the ovaries, does not occur.
[74]
The FIGO ovulatory disorders classification system - Munro - 2022
Aug 19, 2022 · Previously, infrequent ovulation has been termed “oligo-ovulation,” which typically, but not always, manifests with some combination of ...
[75]
Ovulatory Dysfunction - Gynecology and Obstetrics - Merck Manuals
Ovulatory dysfunction is abnormal, irregular (with ≤ 9 menses/year), or absent ovulation. Menses are often irregular or absent. Diagnosis is often possible ...
[76]
Anovulation: Background, Pathophysiology, Etiology
Jan 6, 2023 · Estimates of chronic anovulation rates range from 6-15% of women during the reproductive years.
[77]
Menstruation and Menstrual Disorders: Anovulation | GLOWM
For nonpregnant women aged 16–40 anovulation is considered abnormal and a cause of infertility in 30% of fertility patients. One of the cardinal signs of ...
[78]
Anovulation - PMC - NIH
Disorders of ovulation account for about 30% of infertility and often present with irregular periods (oligomenorrhoea) or an absence of periods (amenorrhoea).
[79]
Current understanding of hypothalamic amenorrhoea - PMC - NIH
It is caused by deficient secretion of hypothalamic gonadotrophin-releasing hormone (GnRH), which in turn leads to failure of pituitary gonadotrophin and ...
[80]
https://www.asrm.org/practice-guidance/practice-committee-documents/diagnosis-and-treatment-of-luteal-phase-deciency-a-committee-opinion-2021/
[81]
Anovulatory Bleeding - StatPearls - NCBI Bookshelf
Mar 23, 2025 · Anovulatory bleeding is a type of abnormal uterine bleeding (AUB) that occurs when ovulation fails to occur during the menstrual cycle.
[82]
Diagnosis and treatment of luteal phase deﬁciency: a committee ...
Potential etiologies of LPD include inadequate progesterone duration, inadequate progesterone levels, or endometrial progesterone resistance.
[83]
A Review of Research on Luteal Phase Deficiency
Aug 12, 2024 · A serum progesterone level of < 10 ng/mL approximately 6-8 days after ovulation may indicate an LPD cycle has occurred. “A serum progesterone ...
[84]
Diagnosis and treatment of luteal phase deficiency: a committee ...
Apr 4, 2021 · Potential etiologies of LPD include inadequate progesterone duration, inadequate progesterone levels, or endometrial progesterone resistance.
[85]
Out-of-Sync Cycle | Science of Aging Knowledge Environment
Out-of-Sync Cycle: Mistimed fertility hormone in older women spurs premature ovulation. Mary BeckmanAuthors Info & Affiliations. Science of Aging Knowledge ...Missing: medications infertility
[86]
Rising Follicle-Stimulating Hormone Levels with Age Accelerate ...
Rising levels of serum FSH with age is at least in part to due to declining inhibin B secretion (6, 7, 21). Inhibin B is known to suppress pituitary FSH ...Hormone Assays · Results · Serum Tg-Fsh, Mouse...
[87]
Optimal Timing of Ovulation Triggering to Achieve Highest Success ...
May 25, 2022 · Low-Dosage Clomiphene Reduces Premature Ovulation Rates and Increases Transfer Rates in Natural-Cycle IVF. Reprod BioMed Online (2014) 29 ...
[88]
Multiple gestation associated with infertility therapy: a committee ...
The risk that a surviving twin will be small for gestational age increases when the demise of its twin occurs after 8 weeks of gestation (8–22 weeks: odd ratio ...
[89]
Strategies to reduce multiple pregnancies due to ovulation stimulation
Patients who consistently developed nine or more follicles ≥10 mm reached cumulative pregnancy rates of 70% by the third COH-IUI cycle, with no additional ...
[90]
Follicular diameters in conception cycles with and without multiple ...
The incidence of multiple pregnancies was associated with higher E2 concentrations and a greater total number of follicles.
[91]
In vitro fertilization (IVF): what are the risks? - ReproductiveFacts.org
There is a small risk (1%) of an ectopic (tubal) pregnancy with IVF; however, this rate is similar to women with a history of infertility. If an ectopic ...
[92]
Ovarian Hyperstimulation Syndrome: A Narrative Review of Its ... - NIH
Ovarian hyperstimulation syndrome (OHSS) is a serious complication of ovulation induction that usually occurs after gonadotropin stimulation.
[93]
Infertility management in women with polycystic ovary syndrome - NIH
Jan 26, 2021 · Pharmacological ovulation induction is the next step, with recommended use of letrozole, clomiphene citrate or gonadotropins. When it fails ...
[94]
Ovulation induction techniques in women with polycystic ovary ...
Aug 12, 2022 · OI with gonadotropins have demonstrated cumulative pregnancy rates of 90% and cumulative live birth rates of 85% after 12 cycles (42).
[95]
Clomiphene - StatPearls - NCBI Bookshelf
Ovarian hyperstimulation syndrome (OHSS) is reported in patients using clomiphene citrate therapy for ovulation induction. OHSS can progress rapidly (within 24 ...
[96]
Clinical outcomes of three- or five-day treatment with clomiphene ...
Sep 30, 2015 · CC induces ovulation in approximately 70% to 85% of patients, but the pregnancy rate is lower than the ovulation rate. This may be due to the ...
[97]
Efficacy of Letrozole vs Clomiphene Citrate for induction of ovulation ...
Letrozole is better treatment choice than clomiphene citrate in PCOS women with infertility in terms of pregnancy and live birth rate.Missing: protocols | Show results with:protocols
[98]
Use of exogenous gonadotropins for ovulation induction in ... - ASRM
A systematic review of 13 studies evaluated ovulation induction with gonadotropins in anovulatory women and found pregnancy rates of 15% per cycle and 41% per ...
[99]
Recommendations from the international evidence-based guideline ...
Letrozole should be considered first line pharmacological treatment for ovulation induction in women with PCOS with anovulatory infertility and no other ...
[100]
A comparative study of fixed-dose, step-down, and low-dose step-up ...
Conclusion: The low-dose step-up regimen of hMG for patients with PCOS may be the safest protocol among the three stimulation regimens for reducing multiple ...
[101]
Ovulation Induction With Gonadotropins | GLOWM
Both ultrasound and estradiol assessment are needed for safe and effective monitoring of ovulation induction. Failure to use both greatly increases the risk ...
[102]
The Success of Ovulation Induction with Letrozole and ... - NIH
Jun 17, 2022 · As compared with clomiphene, letrozole was associated with higher live-birth and ovulation rates among infertile women with the polycystic ovary ...
[103]
Prevention of moderate and severe ovarian hyperstimulation ...
Historically, moderate-to-severe OHSS has been reported to occur in approximately 1%–5% of in vitro fertilization (IVF) cycles (1–5). However, the true ...
[104]
Ovulation Induction: Cost, Success Rates, Risks & Common ...
Aug 10, 2024 · The potential risks of clomiphene citrate and letrozole are very small and include a low (but significant) risk of multiple pregnancy and a very ...
[105]
Oral Contraceptive Pills - StatPearls - NCBI Bookshelf - NIH
The primary mechanism of action is the prevention of ovulation; they inhibit follicular development and prevent ovulation.[1] Progestogen-negative feedback ...
[106]
GnRH agonists in the treatment of symptomatic endometriosis - NIH
Gonadotropin-releasing hormone agonists (GnRHa) are effective in treating the symptoms associated with endometriosis.Missing: ovulation | Show results with:ovulation
[107]
Progestin-Only Pills | Contraception - CDC
Nov 19, 2024 · Unlike norethindrone and norgestrel POPs, the primary mechanism of contraceptive effectiveness of DRSP POPs is ovulation inhibition. In a study ...
[108]
An Evidence-Based Update on Contraception: A detailed ... - NIH
Progestins prevent pregnancy by inhibiting the luteinizing hormone (LH) surge, thus suppressing ovulation, thickening the cervical mucus, lowering fallopian ...
[109]
Emergency contraception review: evidence-based ... - NIH
Ulipristal acetate has been shown to prevent ovulation both before and after the LH surge has started (but before the LH peak), delaying follicular rupture ...
[110]
Progestin-Only Hormonal Birth Control: Pill and Injection - ACOG
Progestin stops ovulation, but it does not do so consistently. About 4 in 10 women who use progestin-only pills will continue to ovulate. Progestin thins ...